Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News 22nd Century Group Inc XXII

Consumer Defensive Tobacco
22nd Century Group, Inc. is an agricultural biotechnology company. The Company is focused on tobacco harm reduction, reduced nicotine tobacco and improving health and wellness through plant science. Additionally, the Company provide contract manufacturing services for conventional combustible tobacco products for third-party brands. The Company operates through a single segment named Tobacco... see more

Recent & Breaking News (NDAQ:XXII)

TrendingWallStreet.com Begins Volume Coverage on BLOX, GRPN, XXII, and DEWM

Accesswire February 12, 2014

22nd Century Group Files For NYSE MKT Listing and NASDAQ Capital Market Listing

Business Wire February 11, 2014

22nd Century Group Delivers Additional Proprietary Research Cigarettes with Various Nicotine Levels

Business Wire February 3, 2014

TrendingWallStreet.com Puts Out Updates on JCP, P, XXII, and FB

Accesswire January 31, 2014

22nd Century Group Files Annual Report and Provides Business Update

Business Wire January 30, 2014

TrendingWallStreet.com Releases Volume Alerts on ARIA, MTOR, XXII, and TPCS

Accesswire December 24, 2013

TrendingWallStreet.com Initiates Coverage on RHT, BBRY, TGRO, and XXII

Accesswire December 23, 2013

22nd Century Group Warrant Exchange Eliminates 93% of Warrant Liability

Business Wire December 16, 2013

22nd Century Group Appoints Richard M. Sanders to Board of Directors

Business Wire December 10, 2013

22nd Century Group Purchases Manufacturing Facility Out of Bankruptcy

Business Wire December 3, 2013

22nd Century Group, Inc. CEO to Webcast, Live, at RetailInvestorConferences.com on December 5th

PR Newswire December 2, 2013

TrendingWallStreet.com Reports Trend Coverage on FTNT, XXII, ARO, and NNRX

Accesswire December 2, 2013

European Patent Allowed for 22nd Century's Nicotine Biosynthesis Genes

Business Wire November 29, 2013

TrendingWallStreet.com Releases Trend Coverage on GGS, VPCO, XXII, and GRPN

Accesswire November 20, 2013

22nd Century Group Paving the Way for Up-Listing to a National Securities Exchange

Business Wire November 18, 2013

Latest Stock Reports on NVGC, FLPC and XXII

Accesswire November 12, 2013

British American Tobacco Licenses 22nd Century Group Technology

Business Wire October 1, 2013

22nd Century Group to Acquire Participating Member of the Tobacco Master Settlement Agreement

Business Wire September 18, 2013

22nd Century Group Announces Allowance of U.S. Patent for Regulating Nicotine in Tobacco with Transcription Factor Gene

Business Wire September 9, 2013

22nd Century Group Announces Early Exercise of Series B Warrants Resulting in Additional $1.25 Million of Proceeds

Business Wire July 24, 2013